ConductScience.org, home

Trial · NCT07877883

Safety, Feasibility, and Acceptability of the MINERVA Voice Conversational Agent for Emergency Department History-Taking

NCT07877883, Enrolling by invitation, Beth Israel Deaconess Medical Center

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Safety, Feasibility, and Acceptability of the MINERVA Voice Conversational Agent for Emergency Department History-Taking. Trials, record NCT07877883. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07877883

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Safety, Feasibility, and Acceptability of the MINERVA Voice Conversational Agent for Emergency Department History-Taking
NCT number
NCT07877883
Status
Enrolling by invitation
Enrollment
250 participants, estimated
Lead sponsor
Beth Israel Deaconess Medical Center
Conditions
History Taking, Artificial Intelligence (AI)
Interventions
MINERVA AI Chatbot
First posted
2026-10-16
Last updated
2026-10-16

Source ClinicalTrials.gov

Registered outcomes8

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimarySafety Diagnoses1 Day
Emergency physicians will review each patient-AI interview transcript using a standardized rubric to determine whether evaluation for possible myocardial infarction, acute stroke, or sepsis is warranted. MINERVA's assessments will be compared with these physician assessments.
SecondarySecondary Safety Diagnoses1 Day
Emergency physicians will review each interview transcript using a standardized rubric to determine whether evaluation for diagnoses including major traumatic injury, aortic syndromes, ovarian/testicular torsion, anaphylaxis, behavioral emergency, major bleeding, pre-eclampsia, other pregnancy emergencies, spinal cord compression, limb ischemia, toxic ingestion, or sickle cell crisis are warranted. MINERVA's assessments will be compared with these physician assessments.
SecondaryConversation completion1 DayWhether interview was completed, terminated early, or patient declined to participate.
SecondaryConversation length1 DayLength of patient interaction with AI conversational agent, measured in number of turns.
SecondaryTurn Length1 DayLength of turns for patient and AI conversational agent, measured in seconds and words.
SecondaryPatient Acceptability of AI Conversational Agent1 Day
Patients will complete an ED Conversational Agent Patient Impressions (ED-CAPI) questionnaire before and after interacting with the chatbot, including components of the following questionnaires: * General Medical Counsel Patient Questionnaire * Practical Assessment of Clinical Examination Skills * Articulate Medical Intelligence Explorer post-provider survey * General Attitudes towards Patient-Facing AI Scale Further questions include: * Ease of use * Perceived value and effects on healthcare system * Willingness to share information with the AI * Accuracy of the AI summary of the interview Responses are aggregated with percent of maximum possible (POMP) methodology. All survey questions are rescaled to a 0-100 scale with 0 the worst possible impression and 100 the best. The final outcome is the 0-100 average of all responses.
SecondaryPhysician Acceptability of AI Conversational Agent3 Months
The panel of ED physicians will review interview transcripts and summaries generated by the AI conversational agent. They will complete an ED Conversational Agent MD Acceptability (ED-CAMA) survey to measure perceived utility of the tool in their clinical workflow.\[
SecondaryPrimary Diagnosis1 Day
The primary diagnosis managed during the patient's emergency department encounter will be assessed via review of emergency department notes as well as admission history and physical and discharge summary when available. Bond score will measure AI diagnostic accuracy relative to the ground truth diagnosis.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07877883

GET https://conductscience.org/api/trials/v1/NCT07877883/registered